The Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical Diseases (Q26797488)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

21 May 2022

The Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical Diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

neglected tropical disease

22 February 2020

main subject

1 reference

PubMed publication ID

26305243

antimicrobial cationic peptides

1 reference

27 September 2020

1 reference

PubMed publication ID

26305243

antimicrobial peptide

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Johannes F Wentzel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Lissinda H du Plessis

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Garmi Jacobs

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

24 August 2015

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

27 September 2020

21 May 2022

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

27 September 2020

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

15392-15433

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

22 February 2020

copyright license

2 references

27 September 2020

21 May 2022

0 references

Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptides stage a comeback

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Cationic peptides: a new source of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Nontuberculous mycobacterial infections: a clinical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Peptide antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Isolation, identification and functional profile of excretory-secretory peptides from Onchocerca ochengi.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

APD2: the updated antimicrobial peptide database and its application in peptide design

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

APD: the Antimicrobial Peptide Database

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Nonribosomal peptide synthetases involved in the production of medically relevant natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Baceridin, a cyclic hexapeptide from an epiphytic bacillus strain, inhibits the proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptides in 2014

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The role of cationic antimicrobial peptides in innate host defences

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Bacteriocins: developing innate immunity for food

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Control of cell selectivity of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Anionic antimicrobial peptides from eukaryotic organisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The potential of antimicrobial peptides as biocides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptides in animals and their role in host defences

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Alpha-helical cationic antimicrobial peptides: relationships of structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Gene-encoded peptide antibiotics and the concept of innate immunity: an update review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Scalable web services for the PSIPRED Protein Analysis Workbench.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptides: a new class of antimalarial drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

θ-Defensins: cyclic peptides with endless potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Avian cathelicidins: paradigms for the development of anti-infectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Functional analysis and induction of four novel goose (Anser cygnoides) avian β-defensins in response to salmonella enteritidis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The salmonid cathelicidins: a gene family with highly varied C-terminal antimicrobial domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Characterization of three novel beta-defensin antimicrobial peptides in rainbow trout (Oncorhynchus mykiss).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Immunocytochemical detection of beta-defensins and cathelicidins in the secretory granules of the tongue in the lizard Anolis carolinensis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Identification and characterization of novel reptile cathelicidins from elapid snakes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Structure-based protein engineering for alpha-amylase inhibitory activity of plant defensin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Refined three-dimensional solution structure of insect defensin A

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Defensins: antimicrobial peptides of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Defensins: "Simple" antimicrobial peptides or broad-spectrum molecules?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

A comprehensive summary of LL-37, the factotum human cathelicidin peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: implication to their mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Mechanisms of antimicrobial peptide action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptide action on parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Fungicidal effect of antimicrobial peptide arenicin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

A carpet-based mechanism for direct antimicrobial peptide activity against vaccinia virus membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Defensins in innate antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Imaging the action of antimicrobial peptides on living bacterial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The relationship between peptide structure and antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Barrel-stave model or toroidal model? A case study on melittin pores.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Inducing toxicity by introducing a leucine-zipper-like motif in frog antimicrobial peptide, magainin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Dual mode of action of Bac7, a proline-rich antibacterial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antibacterial peptides and proteins with multiple cellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

A re-evaluation of the role of host defence peptides in mammalian immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Epithelial Cell-Derived Antibacterial Peptides Human &#946;-Defensins and Cathelicidin: Multifunctional Activities on Mast Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Roles of antimicrobial peptides such as defensins in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antibacterial peptides for therapeutic use: obstacles and realistic outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Deletion of two C-terminal Gln residues of 12-26-residue fragment of melittin improves its antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Hemolytic and antimicrobial activities of the twenty-four individual omission analogues of melittin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Dissection of antibacterial and toxic activity of melittin: a leucine zipper motif plays a crucial role in determining its hemolytic activity but not antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Design, characterization and expression of a novel hybrid peptides melittin (1-13)-LL37 (17-30).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Can innate immunity be enhanced to treat microbial infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Eudragit® L100/N-trimethylchitosan chloride microspheres for oral insulin delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Hybrid melittin cytolytic Peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Reconsidering the underestimated burden caused by neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The effects of maternal helminth and malaria infections on mother-to-child HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Control of neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Rescuing the bottom billion through control of neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptides and self-DNA in autoimmune skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

21 January 2018

On the Origin of Leprosy

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Massive gene decay in the leprosy bacillus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Experimental and Clinical Studies on Rifampicin in Treatment of Leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Iron metabolism and the innate immune response to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antibiotics and antibiotic resistance: a bitter fight against evolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Neglected diseases caused by bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Contribution of sex-linked biology and gender roles to disparities with trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Diagnosis and assessment of trachoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

21 January 2018

Trachoma: an overview

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Natural products for the treatment of trachoma and Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Mass treatment with single-dose azithromycin for trachoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

21 January 2018

Antibiotics for trachoma

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Activity of cathelicidin peptides against Chlamydia spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Induced expression of melittin, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptide from spider venom inhibits Chlamydia trachomatis infection at an early stage

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Effect of induced expression of an antimicrobial peptide melittin on Chlamydia trachomatis and Mycoplasma hominis infections in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Drug repurposing and human parasitic protozoan diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Evaluation and treatment of chagas disease in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Population pharmacokinetics of benznidazole in adult patients with Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Apis mellifera venom induces different cell death pathways in Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Melittin peptide kills Trypanosoma cruzi parasites by inducing different cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Trypanosoma cruzi: synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Magainin analogs effective against pathogenic protozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptides isolated from Phyllomedusa nordestina (Amphibia) alter the permeability of plasma membrane of Leishmania and Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Human African trypanosomiasis

21 January 2018

2 references

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

21 January 2018

12 December 2020

Antibacterial and leishmanicidal activities of temporin-SHd, a 17-residue long membrane-damaging peptide

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Killing of African trypanosomes by antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Advances in Development of New Treatment for Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Temporins, small antimicrobial peptides with leishmanicidal activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Studies on the antileishmanial properties of the antimicrobial peptides temporin A, B and 1Sa.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The role of phosphoglycans in the susceptibility of Leishmania mexicana to the temporin family of anti-microbial peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Anti-leishmanial activity of the antimicrobial peptide DRS 01 observed in Leishmania infantum (syn. Leishmania chagasi) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Leishmania donovani: thionins, plant antimicrobial peptides with leishmanicidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptide-induced apoptotic death of leishmania results from calcium-de pend ent, caspase-independent mitochondrial toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Design of protease-resistant pexiganan enhances antileishmanial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

In vitro activity of Pheroid vesicles containing antibiotics against Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimalarial activities of dermaseptin S4 derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Killer bee molecules: antimicrobial peptides as effector molecules to target sporogonic stages of Plasmodium

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Microscopy and the helminth parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Helminth infections: the great neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

21 January 2018

Helminthic infections

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

How much human helminthiasis is there in the world?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Malnutrition and parasitic helminth infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Protective immune mechanisms in helminth infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Taenia solium: current understanding of laboratory animal models of taeniosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Detection of Taenia solium taeniasis coproantigen is an early indicator of treatment failure for taeniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Taenia solium cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Cathelicidins: family of antimicrobial peptides. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Host-parasite interaction in human onchocerciasis: identification and sequence analysis of a novel human calgranulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Defensins. Natural peptide antibiotics of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Cationic host defence peptides: potential as antiviral therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antiviral drugs: current state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The antimicrobial activity of lactoferrin: current status and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antiviral activities of lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Human alpha-defensins block papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

In vitro antiviral activity of antimicrobial peptides against herpes simplex virus 1, adenovirus, and rotavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Death by design: apoptosis, necrosis and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Induction and function of type I and III interferon in response to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Type I interferons in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Innate immunity to virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antimicrobial peptides: current status and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Dengue virus-mosquito interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Pathogenesis of dengue: challenges to molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Surprising New Dengue Virus Throws a Spanner in Disease Control Efforts

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Evolutionary processes among sylvatic dengue type 2 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Dengue virus life cycle: viral and host factors modulating infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The global distribution and burden of dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Economic and disease burden of dengue in Southeast Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Molecular biology of flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Structural proteomics of dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Ligand-Bound Structures of the Dengue Virus Protease Reveal the Active Conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Inhibition of dengue virus entry into target cells using synthetic antiviral peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Structure of the dengue virus envelope protein after membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Right place, wrong species: a 20-year review of rabies virus cross species transmission among terrestrial mammals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The cell biology of rabies virus: using stealth to reach the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Rabies as a transneuronal tracer of circuits in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The clinical picture of rabies in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Fighting rabies in Africa: the Africa Rabies Expert Bureau (AfroREB).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Functional interaction map of lyssavirus phosphoprotein: identification of the minimal transcription domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

The role of site-specific N-glycosylation in secretion of soluble forms of rabies virus glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Antiviral activity of casein and αs2 casein hydrolysates against the infectious haematopoietic necrosis virus, a rhabdovirus from salmonid fish.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Dual antiviral activity of human alpha-defensin-1 against viral haemorrhagic septicaemia rhabdovirus (VHSV): inactivation of virus particles and induction of a type I interferon-related response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Expression and purification of cyto-insectotoxin (Cit1a) using silkworm larvae targeting for an antimicrobial therapeutic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Recombinant production of antimicrobial peptides in Escherichia coli: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Oral Bioavailability of Insulin Contained in Polysaccharide Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200815392

Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity

21 January 2018

1 reference

12 December 2020

Treatment of mycobacterial infections

1 reference

12 December 2020

The discovery of the leprosy bacillus

1 reference

12 December 2020

Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries

1 reference

12 December 2020

Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia)

1 reference

12 December 2020

Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals

1 reference

12 December 2020

Leprosy: steps along the journey of eradication

1 reference

12 December 2020

Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices

1 reference

12 December 2020

Why do larval helminths avoid the gut of intermediate hosts?

1 reference

12 December 2020

Usefulness of pumpkin seeds combined with areca nut extract in community-based treatment of human taeniasis in northwest Sichuan Province, China

1 reference

12 December 2020

The post-antibiotic era: promising developments in the therapy of infectious diseases

1 reference

12 December 2020

Direct inactivation of viruses by human granulocyte defensins

1 reference

12 December 2020

In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi

1 reference

12 December 2020

Chemical structure of circulin A

1 reference

12 December 2020

A molecular model of membrane excitability

1 reference

12 December 2020

Antiendotoxin activity of cationic peptide antimicrobial agents

1 reference

12 December 2020

Demonstration of binding of dengue virus envelope protein to target cells

1 reference

12 December 2020

Processing of mycobacterial lipids and effects on host responsiveness

1 reference

12 December 2020

Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37

1 reference

12 December 2020

Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils

1 reference

12 December 2020

10.3390/MOLECULES200815392

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

242411

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

242411

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PubMed publication ID

26305243

2 references

Consolidated OpenCitations Corpus – April 2017

242411

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26305243%20AND%20SRC:MED&resulttype=core&format=json